Sophie E. Thomas

Swindon, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A comparison of in-patient mental health rehabilitation services provided by the NHS and independent sector in England: patient and service characteristics.

A comparison of in-patient mental health rehabilitation services provided by the NHS and independent sector in England: patient and service characteristics.

Journal: BJPsych open

Published: July 24, 2026

The impact of the Lab4 probiotic on neurodegenerative processes in a murine Alzheimer's disease model.

The impact of the Lab4 probiotic on neurodegenerative processes in a murine Alzheimer's disease model.

Journal: Frontiers in neuroscience

Published: January 19, 2026

Exploring Medical Student and Staff Perspectives on Clinical Placements: Factors Influencing Attendance and Engagement.

Exploring Medical Student and Staff Perspectives on Clinical Placements: Factors Influencing Attendance and Engagement.

Journal: Cureus

Published: August 07, 2025

Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient survey.

Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient survey.

Journal: Orphanet journal of rare diseases

Published: December 18, 2024

Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities.

Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities.

Journal: Orphanet journal of rare diseases

Published: December 13, 2024

The ability of the Lab4 probiotic consortium to impact upon the functionality of serum deprived human keratinocytes in vitro.

The ability of the Lab4 probiotic consortium to impact upon the functionality of serum deprived human keratinocytes in vitro.

Journal: Frontiers in microbiomes

Published: September 02, 2024

Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer's Disease Model Mice and the SH-SY5Y Neuronal Cell Line.

Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer's Disease Model Mice and the SH-SY5Y Neuronal Cell Line.

Journal: International journal of molecular sciences

Published: December 17, 2022

The burden of disease in metachromatic leukodystrophy: results of a caregiver survey in the UK and Republic of Ireland.

The burden of disease in metachromatic leukodystrophy: results of a caregiver survey in the UK and Republic of Ireland.

Journal: Orphanet journal of rare diseases

Published: November 15, 2022

The importance of early diagnosis and views on newborn screening in metachromatic leukodystrophy: results of a Caregiver Survey in the UK and Republic of Ireland.

The importance of early diagnosis and views on newborn screening in metachromatic leukodystrophy: results of a Caregiver Survey in the UK and Republic of Ireland.

Journal: Orphanet journal of rare diseases

Published: June 23, 2022

The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's Disease.

The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's Disease.

Journal: Frontiers in neuroscience

Published: December 24, 2021

Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature.

Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature.

Journal: Journal of clinical medicine

Published: September 10, 2021

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement.

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement.

Journal: Orphanet journal of rare diseases

Published: August 28, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026